1. Home
  2. SCL vs PCRX Comparison

SCL vs PCRX Comparison

Compare SCL & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCL
  • PCRX
  • Stock Information
  • Founded
  • SCL 1932
  • PCRX 2006
  • Country
  • SCL United States
  • PCRX United States
  • Employees
  • SCL N/A
  • PCRX N/A
  • Industry
  • SCL Package Goods/Cosmetics
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCL Consumer Discretionary
  • PCRX Health Care
  • Exchange
  • SCL Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • SCL 1.3B
  • PCRX 1.2B
  • IPO Year
  • SCL N/A
  • PCRX 2011
  • Fundamental
  • Price
  • SCL $57.01
  • PCRX $22.55
  • Analyst Decision
  • SCL
  • PCRX Buy
  • Analyst Count
  • SCL 0
  • PCRX 8
  • Target Price
  • SCL N/A
  • PCRX $28.38
  • AVG Volume (30 Days)
  • SCL 92.7K
  • PCRX 565.4K
  • Earning Date
  • SCL 07-30-2025
  • PCRX 08-05-2025
  • Dividend Yield
  • SCL 2.70%
  • PCRX N/A
  • EPS Growth
  • SCL 47.62
  • PCRX N/A
  • EPS
  • SCL 2.45
  • PCRX N/A
  • Revenue
  • SCL $2,222,111,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • SCL $8.56
  • PCRX $7.92
  • Revenue Next Year
  • SCL $6.89
  • PCRX $11.02
  • P/E Ratio
  • SCL $23.29
  • PCRX N/A
  • Revenue Growth
  • SCL N/A
  • PCRX 3.08
  • 52 Week Low
  • SCL $44.23
  • PCRX $11.16
  • 52 Week High
  • SCL $91.92
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • SCL 51.00
  • PCRX 43.85
  • Support Level
  • SCL $55.86
  • PCRX $21.26
  • Resistance Level
  • SCL $58.23
  • PCRX $22.95
  • Average True Range (ATR)
  • SCL 1.38
  • PCRX 0.83
  • MACD
  • SCL -0.22
  • PCRX 0.01
  • Stochastic Oscillator
  • SCL 25.19
  • PCRX 48.68

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: